CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms.
about
The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivoActions of Thyroid Hormone Analogues on ChemokinesIntegrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1CX3CR1 tyrosine sulfation enhances fractalkine-induced cell adhesionFractalkine in rheumatoid arthritis and allied conditionsMultimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxisTargeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejectionFunctional significance of mononuclear phagocyte populations generated through adult hematopoiesisSyk regulates multiple signaling pathways leading to CX3CL1 chemotaxis in macrophages.Ly6Chigh Monocytes Protect against Kidney Damage during Sepsis via a CX3CR1-Dependent Adhesion MechanismThe chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans.Circulating Cellular Adhesion Molecules and Cognitive Function: The Coronary Artery Risk Development in Young Adults Study.Generation and analysis of mice lacking the chemokine fractalkineIdentification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer.Fractalkine/CX3CL1: a potential new target for inflammatory diseasesB cells promote hepatic inflammation, biliary cyst formation, and salivary gland inflammation in the NOD.c3c4 model of autoimmune cholangitis.A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patientsChemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.Deciphering the key molecular and cellular events in neutrophil transmigration during acute inflammation.Transcriptome analysis in patients with chronic kidney disease on hemodialysis disclosing a key role for CD16+CX3CR1+ monocytes.Fractalkine receptor CX(3)CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells.The chemokine receptor CX₃CR1 is directly involved in the arrest of breast cancer cells to the skeleton.Fractalkine: a novel angiogenic chemokine in rheumatoid arthritisIn vivo structure/function and expression analysis of the CX3C chemokine fractalkineTouch of chemokines.Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease.Characterization of the rhesus cytomegalovirus US28 locus.Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradientT Cell CX3CR1 Mediates Excess Atherosclerotic Inflammation in Renal Impairment.Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury.Fractalkine in rheumatoid arthritis: a review to date.CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation.Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis.Control of dendritic cell trafficking in lymphatics by chemokines.AR function in promoting metastatic prostate cancerUnique role of the chemokine domain of fractalkine in cell capture. Kinetics of receptor dissociation correlate with cell adhesion.Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis.The chemokine CX3CL1 promotes trafficking of dendritic cells through inflamed lymphatics.Human cytomegalovirus US28 facilitates cell-to-cell viral dissemination.
P2860
Q24685876-4CA42E18-F7E9-4F17-9E85-49A104D8570AQ26738767-33149E7B-A2EF-4B66-955F-D312783828A1Q28119172-E2DFDCED-BC2B-4937-BAA1-B2EA504E13FFQ28209329-4333B891-ED6A-4FA1-A41E-CE670B69083EQ28245416-88E8562A-C595-440C-A206-C0AFA62CC508Q28349180-6D7F5CEE-81AD-47DE-AC15-C7B44E2E5445Q28349698-58F3EC9E-B4EA-453A-A29F-839D281D38BAQ30366001-E1D7B7AD-5AB1-44C2-BE6B-9F4F7D646833Q30427232-853404E1-DD18-4D5F-86EF-C4616B6E3534Q30718708-656A5A26-8FCE-4E18-851C-A97904DCE213Q31160040-14F4C64C-BED0-435D-8EE3-8D97CCDAB9D1Q33685670-B574AD92-2B3F-436B-A573-D7826B6C8EE5Q33720302-0AE7D1E8-01F6-4E09-8D33-9CC56193D2A2Q33941435-C42DFBF0-6140-412D-A8AB-DB3F4DEB8424Q33959320-6ACB91D4-A8E8-46AE-9A67-4F94268189F3Q34407627-8871A883-8349-4B07-89EC-67D61F4E9C3EQ34669460-08663F24-8B31-4845-A6C5-201D1E6B08CFQ34714685-14449246-4B45-4D33-AEC4-4B908EFB064EQ34912596-CB45B1C3-E467-4F89-A6F9-7D869A5CC881Q34951892-93F2DA41-45A4-45B3-AE8D-5A202A35029FQ35241188-1E0087E5-5E20-498A-B9B0-18EE7918F7DEQ35683268-A6EE2C1E-FDE3-42B3-BB98-02ECBB3CC950Q35683552-7C1FA0D8-0F91-4F79-A8DB-DC690DC81666Q35746847-56E09BAE-8EEF-476C-ADE3-157E6B4AD21AQ35865080-AAEA35D4-5D40-4D18-956B-11BA032BFB5CQ36090029-C9AF4050-1C74-466F-A403-8686F54E6F65Q36372735-F05FDAA4-1E3A-4AFB-A36E-EAF052DDF39DQ36525364-EE6C2278-679A-452E-933B-8F8DC7818D5AQ36811526-BAF74D27-E4A5-4161-9745-4EDFFCCFAFD5Q36944695-83641131-DAFE-46BD-A12D-70380E2C4EA1Q37038993-0240042A-6EAC-4C03-AEE6-711F269AA54CQ37170088-A063CFFA-5A44-4FCA-BAB9-65CFE7C6C241Q37234292-0497AEEF-325C-42CC-B704-3A0F5219DDA1Q37378198-CC9B6F7C-1717-48A8-9F9F-0B957A273B65Q38162731-E0A82FD2-BCD9-4509-BA60-12A9A532088CQ38178555-AD3C52E7-8D56-4160-A8DF-3C58AD86CF1DQ38309472-0890C67C-760A-45DB-BCD6-EAA6BAC00776Q38374478-8B33DB44-2875-4931-B724-A2D3434F561DQ38424659-E8A4AF66-AF76-416C-B6FB-0696BBC988DBQ38562379-CD1F58D0-89A1-49F5-9474-83D5C34539C4
P2860
CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
CX3C-chemokine, fractalkine-en ...... t and -independent mechanisms.
@en
type
label
CX3C-chemokine, fractalkine-en ...... t and -independent mechanisms.
@en
prefLabel
CX3C-chemokine, fractalkine-en ...... t and -independent mechanisms.
@en
P2093
P1476
CX3C-chemokine, fractalkine-en ...... t and -independent mechanisms.
@en
P2093
P304
P356
10.4049/JIMMUNOL.164.8.4313
P407
P577
2000-04-01T00:00:00Z